Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. The company also develops Haematokine, a new chemical entity AOC3 inhibitor for the treatment of hematological malignancies and bone marrow. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
| Technical Indicators | Buy | Buy | Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 158.50 | 158.50 | 154.50 | +4.00 | +2.59% | 66.28K | London | |||
| 600.00 | 603.00 | 599.00 | +6.00 | +1.01% | 49.84K | London | |||
| 0.0225 | 0.0225 | 0.0225 | 0.0000 | 0.00% | 0.00 | London | |||
| 110.00 | 110.00 | 110.00 | +5.00 | +4.76% | 39.63K | London | |||
| 78.90 | 81.55 | 78.90 | -0.70 | -0.88% | 2.96M | London | |||
| 669.20 | 710.20 | 668.40 | -8.80 | -1.30% | 269.30K | London | |||
| 754.80 | 775.80 | 738.20 | +11.80 | +1.59% | 1.33M | London | |||
| 157.50 | 157.50 | 157.50 | +5.00 | +3.28% | 61.19K | London | |||
| 2,195.00 | 2,270.00 | 2,180.00 | -30.0 | -1.35% | 120.45K | London | |||
| 1,006.00 | 1,044.00 | 994.40 | +28.80 | +2.95% | 7.33M | London | |||
| 0.62 | 0.61 | 0.61 | +0.01 | +2.05% | 121.72K | London | |||
| 5.49 | 5.50 | 5.49 | 0.00 | 0.00% | 0.00 | London | |||
| 662.00 | 667.00 | 658.00 | +2.00 | +0.30% | 342.82K | London | |||
| 50.00 | 50.00 | 50.00 | 0.00 | 0.00% | 0.00 | London | |||
| 1,130.00 | 1,135.50 | 1,127.00 | +6.00 | +0.53% | 1.17M | London |